Press Releases
WALTHAM, Mass., March 27, 2020 /PRNewswire/ -- Fresenius Medical Care North America (FMCNA), the nation's leading provider of kidney care products and services, today con
Read more...27 March 2020
BOSTON, March 27, 2020 /PRNewswire/ -- Houghton Mifflin Harcourt (HMH) (NASDAQ: HMHC) today announced steps to address COVID-19 and provided a business update related to the pandemic.
Read more...PORTLAND, Ore., March 27, 2020 /PRNewswire/ -- Bright.md, the leading healthcare automation company, has closed an $8 million Series C round of funding co-led by
Read more...27 March 2020
LAS VEGAS, March 27, 2020 /PRNewswire/ -- Living Senior LLC is proud to announce their latest venture, CBDSeniors.com, a web platform that has been created in an effort to promote the us
Read more...27 March 2020
WASHINGTON, March 27, 2020 /PRNewswire/ -- "Today the Alliance launched the I do my part campaign to combat COVID-19. What we each do during this crisis makes a difference. We need to give individuals and families tools to help them through these coming weeks," said Dr. Jane L. Delgado, President and CEO of the National Allia
Read more...27 March 2020
In response to the COVID-19 crisis, Falcon.io will offer complimentary services COPENHAGEN, March 27, 2020 /PRNewswire/ -- Falcon.io, a Cision company, announced it will participate in a
Read more...27 March 2020
SHANGHAI, March 27, 2020 /PRNewswire/ -- China's leading online pharmaceutical network and healthcare service provider is partnering with the Wenjiang People's Hospital in Chengdu to build an online cancer diagnosis and treatment platform for rare tumors using imported drugs. The new rare tumor platform w
Read more...27 March 2020
SANTA BARBARA, Calif., March 27, 2020 /PRNewswire/ -- Seek Thermal, a leading provider of affordable, high-performance thermal imaging products, announces the introduction of
Read more...GERMANTOWN, Md., March 27, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today reported its financial results for the year ended December 31, 2019.Business Highlights for the Year Ended
Read more...27 March 2020
SUZHOU, China, March 27, 2020 /PRNewswire/ -- Alphamab Oncology (stock code: 9966HK) announced today that Jiangsu Alphamab Biopharmaceuticals Co., Ltd. ("Jiangsu Alphamab"), a wholly-owned subsidiary of the Company, has entered a clinical supply agreement with Pfizer Inc. ("Pfizer") to advance a clinical study to investigate KN026 in comb
Read more...